Protalix BioTherapeutics(PLX) - 2021 Q4 - Annual Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION | | | Page | | --- | --- | --- | | | PART I | | | | Cautionary Statement Regarding Forward-Looking Statements and Risk Factors Summary | 1 | | Item 1. | Business | 2 | | Item 1A. | Risk Factors | 32 | | Item 1B. | Unresolved Staff Comments | 58 | | Item 2. | Properties | 58 | | Item 3. | Legal Proceedings | 58 | | Item 4. | Mine Safety Disclosures | 58 | | | PART II | | | Item 5. | Market for Registrant's Common Equity, Related Stockholder M ...